Dow Jones

39,512.84

0.32%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Molecular Insight Pharmaceuticals (MM) (MIPI)
Molecular Insight Pharmaceuticals (MM) (MIPI) Noticias

MIPI

Molecular Insight Pharmaceuticals (MM) (MIPI)

Molecular Insight Pharmaceuticals (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MIPI

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
20/12/2010	18:42	Marketwired	Molecular Insight Announces NASDAQ Decision to Delist Common Stock and Transfer to OTCQB(TM) Marketplace	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
17/12/2010	10:18	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
14/12/2010	15:39	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
09/12/2010	21:46	Marketwired	Molecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management Changes	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/12/2010	18:38	Marketwired	Molecular Insight Receives Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
04/11/2010	12:43	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
04/11/2010	07:21	Marketwired	Molecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial and Operational Results	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
19/10/2010	15:30	Marketwired	Molecular Insight Pharmaceuticals Data Indicate Trofex(TM) May Enable Visualization and Monitoring of Response to Prostate Cance	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
19/10/2010	15:01	Marketwired	Molecular Insight Announces Resignation of Chief Medical Officer	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
14/10/2010	15:49	Marketwired	Molecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for Detec	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
08/10/2010	07:00	Marketwired	Molecular Insight Pharmaceuticals Receives NASDAQ Notification Letters	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
06/10/2010	10:47	Marketwired	Molecular Insight Receives Eleventh Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
17/09/2010	13:58	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
17/09/2010	10:16	Marketwired	Molecular Insight Receives Tenth Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
09/09/2010	07:00	Marketwired	Molecular Insight Receives Ninth Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/09/2010	07:01	Marketwired	Molecular Insight Receives Eighth Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
30/08/2010	16:11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
17/08/2010	07:04	Marketwired	Molecular Insight Receives Seventh Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/08/2010	15:01	Marketwired	Molecular Insight Receives Sixth Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
16/07/2010	07:01	Marketwired	Molecular Insight Receives Fifth Extension of Waiver Agreement with Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
14/07/2010	07:01	Marketwired	Molecular Insight Pharmaceuticals' Zemiva Phase 2 Data Published in Journal of the American College of Cardiology	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
02/07/2010	07:09	Marketwired	Molecular Insight Receives Fourth Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
01/07/2010	05:03	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
30/06/2010	13:49	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/A)	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
25/06/2010	07:01	Marketwired	Molecular Insight Pharmaceuticals Receives NASDAQ Notification Letter	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
23/06/2010	15:01	Marketwired	Molecular Insight Pharmaceuticals Presents Positive Data From Azedra(TM) Phase 2a Clinical Trial in Neuroblastoma Tumors	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
22/06/2010	07:01	Marketwired	Molecular Insight Receives Third Extension of Waiver Agreement With Bond holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
16/06/2010	05:50	GlobeNewswire Inc.	Stock Alert for Molecular Insight Pharmaceuticals Inc. Issued by MicroStockProfit	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
08/06/2010	15:30	Marketwired	Molecular Insight Pharmaceuticals Presents Oncology Data at Society of Nuclear Medicine 2010 Annual Meeting	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)
18/05/2010	07:00	Marketwired	Molecular Insight Receives Second Extension of Waiver Agreement With Bond Holders	NASDAQ:MIPI	Molecular Insight Pharmaceuticals (MM)